These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 694843

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production.
    Lagarde M, Ghazi I, Dechavanne M.
    Prostaglandins Med; 1979 Jun; 2(6):433-9. PubMed ID: 399526
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of platelet aggregation by a new agent, Ticlopidine.
    Ashida SI, Abiko Y.
    Thromb Haemost; 1979 Feb 15; 40(3):542-50. PubMed ID: 425067
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of oral ticlopidine on arachidonic acid products in human platelets.
    Bruno JJ, Chang LF, McSpadden MM, Yang D.
    Agents Actions Suppl; 1984 Feb 15; 15():76-87. PubMed ID: 6435408
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.
    Picard-Fraire C.
    Thromb Res Suppl; 1983 Feb 15; 4():119-28. PubMed ID: 6356462
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL, El Mouelhi M, Pfannkuche HJ, Rose K, Marro M, Angiolillo DJ.
    Am J Ther; 2010 Feb 15; 17(6):543-52. PubMed ID: 19797939
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of human platelet aggregation by phospholipase-A.
    Iatridis SG, Iatridis PG, Markidou SG, Ragatz BH.
    Thromb Res; 1976 Oct 15; 9(4):335-44. PubMed ID: 982355
    [No Abstract] [Full Text] [Related]

  • 16. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI, Abiko Y.
    Thromb Haemost; 1979 Apr 23; 41(2):436-49. PubMed ID: 224522
    [Abstract] [Full Text] [Related]

  • 17. Factors affecting platelet cyclic GMP levels during aggregation induced by collagen and by arachidonic acid.
    Davies T, Davidson MM, McClenaghan MD, Say A, Haslam RJ.
    Thromb Res; 1976 Oct 23; 9(4):387-405. PubMed ID: 185743
    [No Abstract] [Full Text] [Related]

  • 18. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
    Romstedt K, Huzoor-Akbar.
    Thromb Res; 1985 May 15; 38(4):361-74. PubMed ID: 2990062
    [Abstract] [Full Text] [Related]

  • 19. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S, Girish KS, Santhosh MS, Hemshekhar M, Nayaka SC, Kemparaju K.
    Blood Coagul Fibrinolysis; 2013 Jun 15; 24(4):419-23. PubMed ID: 23343693
    [Abstract] [Full Text] [Related]

  • 20. Effects of ticlopidine, a new platelet aggregation inhibitor in man.
    Thebault JJ, Blatrix CE, Blanchard JF, Panak EA.
    Clin Pharmacol Ther; 1975 Oct 15; 18(4):485-90. PubMed ID: 1100310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.